Get started
Author

Katsuhiko Nakatsukasa

Observed names: K. Nakatsukasa, KATSUHIKO NAKATSUKASA, Katsuhiko NAKATSUKASA, Nakatsukasa K, Nakatsukasa Katsuhiko
ORCID: 0000-0002-1411-1436
Observed ORCID: 0000-0002-1411-1436
OpenAlex ID: A5083734869
Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial
2019 · Yuko Kanbayashi, Koichi Sakaguchi, et al. · The Breast · 73
PDF
Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer
2016 · Katsuhiko Nakatsukasa, Hiroshi Koyama, et al. · Breast Cancer · 49
Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis
2016 · A. Yoshida, O. Takahashi, et al. · European Journal of Surgical Oncology · 28
Myoid hamartoma of the breast that proved difficult to diagnose: a case report
2012 · Naruhiko Mizuta, Koichi Sakaguchi, et al. · World Journal of Surgical Oncology · 28
PDF
Comparison of morbidity-related seroma formation following conventional latissimus dorsi flap versus muscle-sparing latissimus dorsi flap breast reconstruction
2017 · Yoshihiro Sowa, Toshiaki Numajiri, et al. · Annals of Surgical Treatment and Research · 26
PDF
Repeat lumpectomy for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: the impact of radiotherapy on second IBTR
2013 · Makoto Ishitobi, Yasuhiro Okumura, et al. · Breast Cancer · 23
Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer
2018 · Katsuhiko Nakatsukasa, Hiroshi Koyama, et al. · Journal of Bone and Mineral Metabolism · 19
Evaluation of the severity of capsular contracture using elastography after breast implant reconstruction
2017 · Yoshihiro Sowa, Isao Yokota, et al. · Clinical Hemorheology and Microcirculation · 18
Effect of denosumab administration on low bone mineral density (T-score −1.0 to −2.5) in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer
2017 · Katsuhiko Nakatsukasa, Hiroshi Koyama, et al. · Journal of Bone and Mineral Metabolism · 17
Breast Cancer Subtype and Distant Recurrence after Ipsilateral Breast Tumor Recurrence
2013 · Makoto Ishitobi, Yasuhiro Okumura, et al. · Annals of Surgical Oncology · 17
Phase II Clinical Trial of First-line Eribulin Plus Trastuzumab for Advanced or Recurrent HER2-positive Breast Cancer
2018 · KOICHI SAKAGUCHI, KATSUHIKO NAKATSUKASA, et al. · Anticancer Research · 16
PDF
Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence
2015 · Y. Okumura, R. Nishimura, et al. · European Journal of Surgical Oncology · 16
Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results
2018 · Katsuhiko Nakatsukasa, Hiroshi Koyama, et al. · Breast Cancer · 14
Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer
2016 · Katsuhiko Nakatsukasa, Hiroshi Koyama, et al. · Breast Cancer · 12
Oral care and oral assessment guide in breast cancer patients receiving everolimus and exemestane: subanalysis of a randomized controlled trial (Oral Care-BC)
2021 · Masahiro Umeda, Yoshihide Ota, et al. · Annals of Translational Medicine · 11
PDF
Effect of denosumab on bone mineral density in Japanese women with osteopenia treated with aromatase inhibitors for breast cancer: subgroup analyses of a Phase II study
2018 · Katsuhiko Nakatsukasa, Hiroshi Koyama, et al. · Therapeutics and Clinical Risk Management · 11
PDF
The effect of denosumab in breast cancer patients receiving adjuvant aromatase inhibitors: 36-month results
2020 · Yoshimi Ouchi, Katsuhiko Nakatsukasa, et al. · Journal of Bone and Mineral Metabolism · 10
Predictive factors for taxane acute pain syndrome determined by ordered logistic regression analysis
2018 · Yuko Kanbayashi, Kouichi Sakaguchi, et al. · Supportive Care in Cancer · 9
Efficacy of denosumab for restoring normal bone mineral density in women receiving adjuvant aromatase inhibitors for early breast cancer
2019 · Koichi Sakaguchi, Hisako Ono, et al. · Medicine · 8
Local recurrence risk after previous salvage mastectomy
2016 · M. Tanabe, T. Iwase, et al. · European Journal of Surgical Oncology · 7
Predictive factors for the efficacy of denosumab in postmenopausal Japanese women with non-metastatic breast cancer receiving adjuvant aromatase inhibitors: a combined analysis of two prospective clinical trials
2019 · Katsuhiko Nakatsukasa, Hiroshi Koyama, et al. · Journal of Bone and Mineral Metabolism · 6
Phase I Study of Triweekly Nab-Paclitaxel Combined with S-1 in Patients with HER2-negative Metastatic Breast Cancer
2016 · KOICHI SAKAGUCHI, KATSUHIKO NAKATSUKASA, et al. · Anticancer Research · 6
PDF
Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observational KBCRN A001: E-SPEC study
2022 · Yuichiro Kikawa, Takeshi Kotake, et al. · Breast Cancer · 5
PDF
Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC
2021 · Katsuhiko Nakatsukasa, Naoki Niikura, et al. · BMC Cancer · 4
PDF
Untitled
2008 · Hiroo Nakajima, Koichi Sakaguchi, et al. · Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) · 4
PDF
Works count: 65
Citation count: 463
H-index: 13
I10-index: 17
Year
Topic
Type